Impact of a new levonorgestrel intrauterine system, Levosert^®, on heavy menstrual bleeding: results of a one-year randomised controlled trial

REFERENCES

• Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol 2003;188:343–8.
   PubMed Web of Science ®Google Scholar
• Santer M, Warner P, Wyke S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. J Clin Epidemiol 2005;58:1206–10.
   PubMed Web of Science ®Google Scholar
• Coulter A, Bradlow J, Agass M, et al. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: An audit of general practice records. Br J Obstet Gynaecol 1991;98:789–96.
   PubMedGoogle Scholar
• Bradlow J, Coulter A, Brooks P. Patterns of referral: A study of referrals to outpatient clinics from general practices in the Oxford Region. Oxford: Health Services Research Unit 1992.
   Google Scholar
• Duckitt K. Managing perimenopausal menorrhagia. Maturitas 2010;66:251–6.
   PubMed Web of Science ®Google Scholar
• Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw 1971;78:933–9.
   PubMedGoogle Scholar
• Janssen CA, Scholten PC, Heintz AP. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid?Eur J Obstet Gynecol Reprod Biol 1998;78:69–72.
   PubMed Web of Science ®Google Scholar
• Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss – a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320–51.
   PubMed Web of Science ®Google Scholar
• Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: A survey with follow-up data. Am J Obstet Gynecol 2004;190:1216–23.
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3–13.
   PubMed Web of Science ®Google Scholar
• Edlund M. Nonhormonal treatments for heavy menstrual bleeding. J Womens Health (Larchmt) 2011;20: 1645–53.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Bissonnette F, Monteiro I, et al. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: A randomized controlled trial. Obstet Gynecol 2010;116:625–32.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Meredith S, Inki P, et al. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: A systematic review and meta-analysis. Obstet Gynecol 2009;113:1104–16.
   PubMed Web of Science ®Google Scholar
• Kucuk T, Ertan K. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: A randomized, prospective, controlled clinical trial in female smokers. Clin Exp Obstet Gynecol 2008;35:57–60.
   PubMed Web of Science ®Google Scholar
• Irvine GA, Campbell-Brown MB, Lumsden MA, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998; 105:592–8.
   PubMedGoogle Scholar
• Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005: CD002126.
   PubMed Web of Science ®Google Scholar
• International Conference in Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline Pharmaceutical Development Q8(R2). August2009. Accessed 13 January 2014 from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf
   Google Scholar
• Code of Federal Regulation. Part 820 Quality System Regulation – Section 820.30 Design Controls. 2013. 18–10–2013.
   Google Scholar
• Wyatt KM, Dimmock PW, Walker TJ, et al. Determination of total menstrual blood loss. Fertil Steril 2001;76:125–31.
   PubMed Web of Science ®Google Scholar
• Stéphanie R, Labied S, Blacher S, et al. Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Hum Reprod 2007;22:3084–91.
   PubMed Web of Science ®Google Scholar
• Xiao B, Wu SC, Chong J, et al. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 2003; 79:963–9.
   PubMed Web of Science ®Google Scholar
• Kriplani A, Singh BM, Lal S, et al. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet 2007;97:190–4.
   PubMed Web of Science ®Google Scholar
• Shaw RW, Symonds IM, Tamizian O, et al. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol 2007;47:335–40.
   PubMed Web of Science ®Google Scholar
• Barrington JW, Arunkalaivanan AS, Abdel-Fattah M. Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol 2003;108:72–4.
   PubMed Web of Science ®Google Scholar
• Mercorio F, De SR, Di Spiezio SA, et al. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception 2003;67:277–80.
   PubMed Web of Science ®Google Scholar
• Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005;112:1121–5.
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel- releasing intrauterine device. Fertil Steril 1997;68:426–9.
   PubMed Web of Science ®Google Scholar
• Busfield RA, Farquhar CM, Sowter MC, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006;113:257–63.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Vercellini P, Mosconi P, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257–63.
   PubMed Web of Science ®Google Scholar
• Grigorieva V, Chen-Mok M, Tarasova M, et al. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003;79:1194–8.
   PubMed Web of Science ®Google Scholar
• Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004;104:1314–21.
   PubMed Web of Science ®Google Scholar
• Milman N, Clausen J, Byg KE. Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 1998;77:13–9.
   PubMed Web of Science ®Google Scholar
• Heikkila M, Nylander P, Luukkainen T. Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device. Contraception 1982;26:465–74.
   PubMed Web of Science ®Google Scholar
• Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456–63.
   PubMed Web of Science ®Google Scholar
• New intrauterine device now is in research. Contraceptive Technology Update 2013. Accessed 13 January 2014 from: http://connection.ebscohost.com/c/articles/90130176/new-intrauterine-device-now-research
   Google Scholar